Biotechnology
The Biotechnology industry has a total of 604 stocks, with a combined market cap of $1.11 trillion and total revenue of $105.22 billion.
Market Cap
1.11T
Revenue
105.22B
Profits
-42.06B
PE Ratio
n/a
Profit Margin
-39.98%
Dividend Yield
0.04%
604 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 112.81B | 1.75% | 999,755 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 74.51B | 4.86% | 1,316,662 | 14.25B |
| 3 | ARGX | argenx SE | 54.90B | 0.08% | 333,944 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 53.43B | -2.59% | 1,188,960 | 3.21B |
| 5 | INSM | Insmed Incorporated | 40.49B | -2.22% | 2,484,801 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 35.71B | 1.25% | 140,591 | 4.97B |
| 7 | BNTX | BioNTech SE | 23.02B | -0.12% | 958,274 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.09B | 0.45% | 3,360,045 | 2.35B |
| 9 | GMAB | Genmab A/S | 19.13B | 1.00% | 1,684,221 | 3.85B |
| 10 | INCY | Incyte Corporation | 18.68B | 0.01% | 1,872,115 | 4.81B |
| 11 | RVMD | Revolution Medicines, Inc. | 15.06B | 0.09% | 2,328,230 | - |
| 12 | ROIV | Roivant Sciences Ltd. | 14.08B | -0.93% | 4,826,850 | 20.33M |
| 13 | BBIO | BridgeBio Pharma, Inc. | 14.01B | 1.44% | 1,606,415 | 353.78M |
| 14 | SMMT | Summit Therapeutics Inc. | 13.83B | 5.41% | 2,973,533 | - |
| 15 | IONS | Ionis Pharmaceuticals, Inc. | 12.74B | -0.29% | 2,659,323 | 966.96M |
| 16 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.55B | -0.26% | 315,988 | 740.64M |
| 17 | ASND | Ascendis Pharma A/S | 12.30B | 2.34% | 1,124,118 | 758.59M |
| 18 | MRNA | Moderna, Inc. | 11.34B | 2.80% | 7,685,972 | 2.23B |
| 19 | EXEL | Exelixis, Inc. | 11.06B | -1.91% | 3,239,688 | 2.29B |
| 20 | RNA | Avidity Biosciences, Inc. | 10.75B | 0.07% | 2,092,975 | 20.87M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.32B | -0.07% | 2,669,618 | 3.09B |
| 22 | ABVX | ABIVAX Société Anonyme | 10.12B | 3.65% | 3,919,848 | 7.07M |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 10.02B | 1.67% | 1,387,947 | 4.16B |
| 24 | TECH | Bio-Techne Corporation | 9.48B | 3.42% | 2,301,051 | 1.22B |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.35B | 0.06% | 4,294,487 | 829.45M |
| 26 | CORT | Corcept Therapeutics Incorporated | 8.97B | 2.60% | 653,923 | 741.17M |
| 27 | NUVL | Nuvalent, Inc. | 8.21B | 0.62% | 435,692 | - |
| 28 | CAI | Caris Life Sciences, Inc. | 7.65B | -0.18% | 3,323,463 | 649.06M |
| 29 | AXSM | Axsome Therapeutics, Inc. | 7.52B | 2.78% | 406,310 | 561.26M |
| 30 | CYTK | Cytokinetics, Incorporated | 7.37B | -2.09% | 2,240,035 | 87.21M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.37B | 1.26% | 1,600,428 | 1.24B |
| 32 | MRUS | Merus N.V. | 7.34B | 0.43% | 3,129,215 | 56.61M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.99B | 4.03% | 820,043 | 174.33M |
| 34 | KRYS | Krystal Biotech, Inc. | 6.95B | 2.17% | 498,799 | 373.16M |
| 35 | CDTX | Cidara Therapeutics, Inc. | 6.90B | -0.31% | 808,831 | 302.00K |
| 36 | PRAX | Praxis Precision Medicines, Inc. | 6.54B | 1.34% | 1,051,439 | 7.46M |
| 37 | KYMR | Kymera Therapeutics, Inc. | 6.47B | 3.46% | 4,459,975 | 43.74M |
| 38 | COGT | Cogent Biosciences, Inc. | 5.96B | 1.66% | 2,533,799 | - |
| 39 | PTCT | PTC Therapeutics, Inc. | 5.95B | 0.86% | 1,184,460 | 1.78B |
| 40 | PTGX | Protagonist Therapeutics, Inc. | 5.71B | 3.18% | 1,308,400 | 209.22M |
| 41 | PCVX | Vaxcyte, Inc. | 5.69B | -2.79% | 1,451,892 | - |
| 42 | CRSP | CRISPR Therapeutics AG | 5.49B | 0.96% | 1,570,928 | 38.34M |
| 43 | APGE | Apogee Therapeutics, Inc. | 5.13B | 1.77% | 902,323 | - |
| 44 | BLTE | Belite Bio, Inc | 5.13B | -1.43% | 207,885 | - |
| 45 | ADMA | ADMA Biologics, Inc. | 4.76B | 0.91% | 1,816,222 | 488.56M |
| 46 | CELC | Celcuity Inc. | 4.71B | -0.87% | 808,914 | - |
| 47 | SRRK | Scholar Rock Holding Corporation | 4.60B | 0.94% | 982,983 | - |
| 48 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.56B | 0.33% | 564,881 | 1.54M |
| 49 | ACAD | ACADIA Pharmaceuticals Inc. | 4.54B | -0.30% | 1,731,820 | 1.05B |
| 50 | TGTX | TG Therapeutics, Inc. | 4.47B | 0.56% | 1,723,319 | 531.90M |
| 51 | CNTA | Centessa Pharmaceuticals plc | 4.32B | 3.39% | 972,564 | 15.00M |
| 52 | LEGN | Legend Biotech Corporation | 4.31B | -2.18% | 3,286,905 | 909.05M |
| 53 | VKTX | Viking Therapeutics, Inc. | 4.24B | 0.67% | 1,965,443 | - |
| 54 | GPCR | Structure Therapeutics Inc. | 4.18B | 3.30% | 4,468,982 | - |
| 55 | ACLX | Arcellx, Inc. | 4.16B | 1.61% | 1,059,124 | 35.90M |
| 56 | IMVT | Immunovant, Inc. | 4.13B | 3.51% | 1,064,898 | - |
| 57 | NAMS | NewAmsterdam Pharma Company N.V. | 4.04B | 2.33% | 1,272,114 | 35.24M |
| 58 | TERN | Terns Pharmaceuticals, Inc. | 4.02B | 4.79% | 11,396,596 | - |
| 59 | ARQT | Arcutis Biotherapeutics, Inc. | 3.65B | 0.03% | 1,292,962 | 317.93M |
| 60 | IRON | Disc Medicine, Inc. | 3.51B | 1.23% | 304,002 | - |
| 61 | RARE | Ultragenyx Pharmaceutical Inc. | 3.47B | -0.83% | 1,684,749 | 630.60M |
| 62 | TARS | Tarsus Pharmaceuticals, Inc. | 3.45B | 2.23% | 719,749 | 366.10M |
| 63 | WVE | Wave Life Sciences Ltd. | 3.38B | -5.07% | 17,633,899 | 109.23M |
| 64 | CGON | CG Oncology, Inc. | 3.37B | - | 571,247 | 2.17M |
| 65 | XENE | Xenon Pharmaceuticals Inc. | 3.36B | -0.18% | 722,719 | 7.50M |
| 66 | MIRM | Mirum Pharmaceuticals, Inc. | 3.32B | -1.12% | 727,806 | 471.79M |
| 67 | OCUL | Ocular Therapeutix, Inc. | 3.28B | -3.39% | 3,793,259 | 55.78M |
| 68 | TLX | Telix Pharmaceuticals Limited | 3.15B | 3.12% | 222,136 | 664.23M |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.14B | 1.32% | 2,406,872 | 240.00M |
| 70 | APLS | Apellis Pharmaceuticals, Inc. | 3.12B | 3.78% | 1,980,375 | 1.02B |
| 71 | VRDN | Viridian Therapeutics, Inc. | 3.11B | 2.52% | 2,399,341 | 70.79M |
| 72 | TVTX | Travere Therapeutics, Inc. | 3.08B | -0.38% | 1,150,857 | 435.83M |
| 73 | FOLD | Amicus Therapeutics, Inc. | 3.04B | 0.41% | 4,206,348 | 598.70M |
| 74 | IDYA | IDEAYA Biosciences, Inc. | 2.95B | -1.29% | 987,556 | 214.83M |
| 75 | MLYS | Mineralys Therapeutics, Inc. | 2.86B | -1.44% | 2,049,045 | - |
| 76 | LQDA | Liquidia Corporation | 2.84B | -4.00% | 1,849,829 | 69.22M |
| 77 | VERA | Vera Therapeutics, Inc. | 2.83B | -0.72% | 2,830,411 | - |
| 78 | DYN | Dyne Therapeutics, Inc. | 2.81B | 6.78% | 9,976,509 | - |
| 79 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.80B | 1.11% | 1,559,965 | 578.20M |
| 80 | AAPG | Ascentage Pharma Group International | 2.79B | -1.93% | 8,789 | 54.52M |
| 81 | BEAM | Beam Therapeutics Inc. | 2.70B | 3.47% | 1,640,936 | 55.70M |
| 82 | SYRE | Spyre Therapeutics, Inc. | 2.69B | 2.91% | 765,699 | - |
| 83 | NUVB | Nuvation Bio Inc. | 2.69B | -2.00% | 5,987,863 | 26.75M |
| 84 | SLNO | Soleno Therapeutics, Inc. | 2.69B | -0.02% | 1,321,080 | 98.68M |
| 85 | DNLI | Denali Therapeutics Inc. | 2.58B | -10.63% | 6,063,669 | - |
| 86 | EWTX | Edgewise Therapeutics, Inc. | 2.51B | 1.71% | 1,048,742 | - |
| 87 | RXRX | Recursion Pharmaceuticals, Inc. | 2.48B | - | 13,676,135 | 43.69M |
| 88 | OLMA | Olema Pharmaceuticals, Inc. | 2.41B | 15.43% | 7,806,131 | - |
| 89 | ADPT | Adaptive Biotechnologies Corporation | 2.40B | 5.92% | 4,365,189 | 252.75M |
| 90 | MESO | Mesoblast Limited | 2.33B | 1.55% | 294,948 | 17.20M |
| 91 | SRPT | Sarepta Therapeutics, Inc. | 2.33B | 0.14% | 3,103,524 | 2.41B |
| 92 | IBRX | ImmunityBio, Inc. | 2.27B | 3.60% | 11,119,047 | 82.56M |
| 93 | HRMY | Harmony Biosciences Holdings, Inc. | 2.26B | 1.16% | 732,369 | 825.94M |
| 94 | GLPG | Galapagos NV | 2.12B | 2.21% | 104,148 | 336.64M |
| 95 | ZBIO | Zenas BioPharma, Inc. | 2.10B | 2.46% | 285,178 | 15.00M |
| 96 | AUPH | Aurinia Pharmaceuticals Inc. | 2.04B | -0.39% | 1,651,612 | 265.81M |
| 97 | ZLAB | Zai Lab Limited | 2.03B | -2.25% | 571,490 | 441.63M |
| 98 | NRIX | Nurix Therapeutics, Inc. | 1.99B | 0.31% | 2,095,599 | 83.69M |
| 99 | STOK | Stoke Therapeutics, Inc. | 1.95B | 12.08% | 1,820,920 | 205.63M |
| 100 | ZYME | Zymeworks Inc. | 1.94B | 0.23% | 698,806 | 134.48M |
| 101 | VCEL | Vericel Corporation | 1.90B | -1.93% | 545,580 | 258.72M |
| 102 | CLDX | Celldex Therapeutics, Inc. | 1.87B | 0.36% | 895,951 | 2.60M |
| 103 | DNTH | Dianthus Therapeutics, Inc. | 1.87B | - | 356,514 | 3.08M |
| 104 | IMNM | Immunome, Inc. | 1.86B | 6.51% | 1,006,007 | 9.68M |
| 105 | MAZE | Maze Therapeutics, Inc. | 1.86B | -5.27% | 482,752 | 2.50M |
| 106 | SION | Sionna Therapeutics, Inc. | 1.84B | -0.91% | 234,441 | - |
| 107 | IMCR | Immunocore Holdings plc | 1.82B | -1.80% | 262,151 | 379.59M |
| 108 | TRVI | Trevi Therapeutics, Inc. | 1.82B | 9.08% | 4,584,486 | - |
| 109 | MNKD | MannKind Corporation | 1.79B | 1.21% | 3,331,364 | 313.79M |
| 110 | SNDX | Syndax Pharmaceuticals, Inc. | 1.79B | 5.69% | 2,400,501 | 111.30M |
| 111 | CAPR | Capricor Therapeutics, Inc. | 1.65B | 4.71% | 2,029,638 | 11.13M |
| 112 | AGIO | Agios Pharmaceuticals, Inc. | 1.63B | 4.28% | 1,630,066 | 44.79M |
| 113 | SVRA | Savara Inc. | 1.61B | 3.72% | 6,013,906 | - |
| 114 | ATAI | Atai Beckley N.V. | 1.57B | -1.37% | 2,021,766 | 3.02M |
| 115 | UPB | Upstream Bio, Inc. | 1.55B | 1.06% | 342,285 | 2.80M |
| 116 | INVA | Innoviva, Inc. | 1.54B | -0.43% | 678,254 | 388.52M |
| 117 | PHVS | Pharvaris N.V. | 1.54B | -1.50% | 420,941 | - |
| 118 | TSHA | Taysha Gene Therapies, Inc. | 1.52B | 4.71% | 3,362,637 | 6.31M |
| 119 | ORKA | Oruka Therapeutics, Inc. | 1.52B | 1.98% | 407,998 | - |
| 120 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.45B | -0.08% | 1,246,168 | -665.00K |
| 121 | ARDX | Ardelyx, Inc. | 1.44B | 2.07% | 3,011,349 | 398.23M |
| 122 | BHVN | Biohaven Ltd. | 1.41B | 1.15% | 2,688,595 | - |
| 123 | FTRE | Fortrea Holdings Inc. | 1.40B | 5.21% | 1,417,554 | 2.76B |
| 124 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.38B | -2.11% | 1,201,343 | 42.34M |
| 125 | RAPP | Rapport Therapeutics, Inc. | 1.37B | 0.07% | 289,049 | - |
| 126 | SANA | Sana Biotechnology, Inc. | 1.32B | 13.56% | 5,345,758 | - |
| 127 | RLAY | Relay Therapeutics, Inc. | 1.32B | 0.13% | 6,084,826 | 8.36M |
| 128 | KOD | Kodiak Sciences Inc. | 1.30B | -1.96% | 467,431 | - |
| 129 | MBX | MBX Biosciences, Inc. | 1.29B | 0.49% | 717,213 | - |
| 130 | ALMS | Alumis Inc. | 1.26B | 5.95% | 1,147,182 | 22.12M |
| 131 | QURE | uniQure N.V. | 1.25B | -3.08% | 1,919,731 | 15.75M |
| 132 | ANAB | AnaptysBio, Inc. | 1.24B | 2.63% | 318,248 | 169.47M |
| 133 | PGEN | Precigen, Inc. | 1.24B | - | 3,916,892 | 6.31M |
| 134 | TNGX | Tango Therapeutics, Inc. | 1.23B | 0.55% | 1,449,021 | 66.50M |
| 135 | INBX | Inhibrx Biosciences, Inc. | 1.23B | -4.93% | 285,429 | 1.40M |
| 136 | XNCR | Xencor, Inc. | 1.23B | 2.08% | 610,991 | 150.13M |
| 137 | IMTX | Immatics N.V. | 1.22B | -0.20% | 536,284 | 99.45M |
| 138 | MNMD | Mind Medicine (MindMed) Inc. | 1.22B | -0.96% | 1,806,376 | - |
| 139 | ELVN | Enliven Therapeutics, Inc. | 1.20B | 3.49% | 1,095,001 | - |
| 140 | OCS | Oculis Holding AG | 1.19B | 0.54% | 17,368 | 992.00K |
| 141 | TYRA | Tyra Biosciences, Inc. | 1.19B | 0.77% | 388,475 | - |
| 142 | PHAR | Pharming Group N.V. | 1.18B | 0.82% | 8,893 | 362.27M |
| 143 | NKTR | Nektar Therapeutics | 1.17B | -1.77% | 697,138 | 62.60M |
| 144 | PVLA | Palvella Therapeutics, Inc. | 1.15B | -1.58% | 120,935 | - |
| 145 | XERS | Xeris Biopharma Holdings, Inc. | 1.15B | -1.00% | 2,436,347 | 266.14M |
| 146 | CVAC | CureVac N.V. | 1.15B | -0.20% | 553,400 | 83.00M |
| 147 | SEPN | Septerna, Inc. | 1.15B | 0.55% | 346,735 | 22.05M |
| 148 | ABCL | AbCellera Biologics Inc. | 1.13B | 2.45% | 3,182,480 | 35.33M |
| 149 | GLUE | Monte Rosa Therapeutics, Inc. | 1.12B | 1.41% | 920,801 | 181.54M |
| 150 | NVAX | Novavax, Inc. | 1.10B | 1.20% | 3,162,546 | 1.06B |
| 151 | NTLA | Intellia Therapeutics, Inc. | 1.09B | 0.75% | 2,754,028 | 57.53M |
| 152 | NBTX | Nanobiotix S.A. | 1.08B | 5.74% | 98,905 | 11.93M |
| 153 | BCAX | Bicara Therapeutics Inc. | 1.05B | 2.08% | 438,650 | - |
| 154 | MLTX | MoonLake Immunotherapeutics | 1.04B | 0.41% | 1,294,978 | - |
| 155 | URGN | UroGen Pharma Ltd. | 1.04B | -2.25% | 904,112 | 96.52M |
| 156 | MDXG | MiMedx Group, Inc. | 1.03B | - | 1,139,357 | 393.44M |
| 157 | SPRY | ARS Pharmaceuticals, Inc. | 1.03B | 5.14% | 2,393,917 | 142.77M |
| 158 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 1.03B | 2.79% | 148,179 | - |
| 159 | RAPT | RAPT Therapeutics, Inc. | 1.01B | 3.68% | 473,982 | - |
| 160 | RZLT | Rezolute, Inc. | 1.01B | 11.07% | 3,270,778 | - |
| 161 | PHAT | Phathom Pharmaceuticals, Inc. | 1.01B | 2.39% | 671,389 | 147.19M |
| 162 | AVBP | ArriVent BioPharma, Inc. | 1.01B | -2.25% | 526,063 | - |
| 163 | ORIC | ORIC Pharmaceuticals, Inc. | 973.89M | -1.38% | 993,693 | - |
| 164 | MRVI | Maravai LifeSciences Holdings, Inc. | 953.79M | 1.08% | 2,861,232 | 192.44M |
| 165 | JANX | Janux Therapeutics, Inc. | 937.10M | -1.02% | 1,900,073 | 10.00M |
| 166 | KURA | Kura Oncology, Inc. | 934.57M | 0.66% | 1,478,193 | 104.03M |
| 167 | CMPX | Compass Therapeutics, Inc. | 933.78M | 2.14% | 1,596,232 | 850.00K |
| 168 | ERAS | Erasca, Inc. | 924.90M | -1.21% | 1,665,048 | - |
| 169 | VIR | Vir Biotechnology, Inc. | 911.27M | -1.65% | 1,778,858 | 16.86M |
| 170 | CRMD | CorMedix Inc. | 903.71M | -1.29% | 3,587,356 | 214.30M |
| 171 | MPLT | MapLight Therapeutics, Inc. | 898.14M | 9.18% | 377,260 | - |
| 172 | IOVA | Iovance Biotherapeutics, Inc. | 897.15M | 0.44% | 7,327,407 | 250.43M |
| 173 | TBPH | Theravance Biopharma, Inc. | 892.34M | -1.12% | 521,212 | 80.33M |
| 174 | ABUS | Arbutus Biopharma Corporation | 882.77M | 2.91% | 1,012,420 | 14.61M |
| 175 | GHRS | GH Research PLC | 882.06M | -0.63% | 136,926 | - |
| 176 | YDES | YD Bio Limited | 881.11M | -0.40% | 44,803 | 510.36K |
| 177 | DAWN | Day One Biopharmaceuticals, Inc. | 873.77M | 3.15% | 2,825,498 | 133.67M |
| 178 | KALV | KalVista Pharmaceuticals, Inc. | 852.21M | 4.33% | 878,480 | 1.43M |
| 179 | IVA | Inventiva S.A. | 847.70M | 5.16% | 554,642 | 19.93M |
| 180 | ARVN | Arvinas, Inc. | 833.63M | -0.92% | 1,151,890 | 312.30M |
| 181 | GERN | Geron Corporation | 817.09M | 4.07% | 6,682,465 | 183.40M |
| 182 | GOSS | Gossamer Bio, Inc. | 807.78M | 1.16% | 3,050,940 | 44.05M |
| 183 | OMER | Omeros Corporation | 796.92M | -2.01% | 1,200,868 | - |
| 184 | LENZ | LENZ Therapeutics, Inc. | 783.50M | -5.33% | 1,147,745 | 17.50M |
| 185 | VSTM | Verastem, Inc. | 772.59M | -1.09% | 1,463,373 | 13.38M |
| 186 | REPL | Replimune Group, Inc. | 770.31M | -4.66% | 2,053,283 | - |
| 187 | GYRE | Gyre Therapeutics, Inc. | 768.93M | 5.22% | 134,193 | 107.27M |
| 188 | PRME | Prime Medicine, Inc. | 766.58M | 3.34% | 3,930,537 | 5.98M |
| 189 | VALN | Valneva SE | 758.05M | 3.02% | 29,640 | 211.09M |
| 190 | RIGL | Rigel Pharmaceuticals, Inc. | 748.20M | -2.62% | 416,029 | 282.08M |
| 191 | FULC | Fulcrum Therapeutics, Inc. | 746.83M | -5.48% | 4,417,920 | 80.00M |
| 192 | ATXS | Astria Therapeutics, Inc. | 740.39M | 0.15% | 980,820 | 706.00K |
| 193 | CGEM | Cullinan Therapeutics, Inc. | 736.09M | 0.81% | 1,383,046 | - |
| 194 | ANNX | Annexon, Inc. | 730.37M | 0.82% | 1,665,203 | - |
| 195 | LXEO | Lexeo Therapeutics, Inc. | 710.17M | 2.31% | 993,381 | - |
| 196 | DBVT | DBV Technologies S.A. | 693.69M | 16.55% | 680,317 | 5.50M |
| 197 | MGTX | MeiraGTx Holdings plc | 675.32M | -0.59% | 312,674 | 27.42M |
| 198 | LYEL | Lyell Immunopharma, Inc. | 663.71M | 6.87% | 86,611 | 41.00K |
| 199 | RGNX | REGENXBIO Inc. | 661.14M | 2.67% | 701,985 | 161.32M |
| 200 | CTMX | CytomX Therapeutics, Inc. | 660.80M | 0.26% | 1,126,460 | 113.63M |
| 201 | DRUG | Bright Minds Biosciences Inc. | 660.67M | 9.03% | 88,303 | - |
| 202 | PROK | ProKidney Corp. | 652.81M | -1.81% | 1,019,235 | 744.00K |
| 203 | CRVS | Corvus Pharmaceuticals, Inc. | 634.05M | -2.08% | 1,203,711 | - |
| 204 | JBIO | Jade Biosciences, Inc. | 620.60M | -0.07% | 343,767 | - |
| 205 | VTYX | Ventyx Biosciences, Inc. | 620.11M | 2.12% | 836,986 | - |
| 206 | FDMT | 4D Molecular Therapeutics, Inc. | 618.77M | 3.04% | 689,131 | 120.00K |
| 207 | ABSI | Absci Corporation | 596.97M | 12.78% | 7,682,318 | 2.82M |
| 208 | EVMN | Evommune, Inc. | 589.82M | 9.92% | 253,690 | 3.00M |
| 209 | IVVD | Invivyd, Inc. | 585.14M | 1.21% | 5,398,949 | 50.04M |
| 210 | ASMB | Assembly Biosciences, Inc. | 568.39M | 0.74% | 119,975 | 37.19M |
| 211 | ALT | Altimmune, Inc. | 566.58M | -1.63% | 3,348,671 | 20.00K |
| 212 | DNA | Ginkgo Bioworks Holdings, Inc. | 555.86M | 2.30% | 1,104,345 | 180.61M |
| 213 | LBRX | LB Pharmaceuticals Inc | 540.39M | -2.82% | 256,020 | - |
| 214 | DSGN | Design Therapeutics, Inc. | 536.60M | 1.62% | 202,597 | - |
| 215 | ENGN | enGene Holdings Inc. | 535.65M | -2.67% | 185,278 | - |
| 216 | PRTA | Prothena Corporation plc | 531.30M | -4.36% | 961,391 | 11.79M |
| 217 | NAGE | Niagen Bioscience, Inc. | 526.99M | 1.08% | 725,574 | 124.71M |
| 218 | MNPR | Monopar Therapeutics Inc. | 522.71M | 3.69% | 164,803 | - |
| 219 | BCYC | Bicycle Therapeutics plc | 521.65M | 6.06% | 288,898 | 28.34M |
| 220 | ADCT | ADC Therapeutics SA | 496.75M | 13.60% | 2,510,777 | 75.21M |
| 221 | DMAC | DiaMedica Therapeutics Inc. | 486.92M | 3.09% | 1,016,353 | - |
| 222 | LXRX | Lexicon Pharmaceuticals, Inc. | 479.69M | 0.76% | 1,248,420 | 70.86M |
| 223 | ZVRA | Zevra Therapeutics, Inc. | 475.71M | -1.52% | 861,642 | 84.39M |
| 224 | NBP | NovaBridge Biosciences | 471.44M | 1.74% | 305,940 | - |
| 225 | SLDB | Solid Biosciences Inc. | 458.11M | 2.26% | 743,942 | - |
| 226 | ANRO | Alto Neuroscience, Inc. | 443.63M | 7.77% | 291,645 | - |
| 227 | BNTC | Benitec Biopharma Inc. | 433.78M | -3.83% | 184,169 | - |
| 228 | DRTS | Alpha Tau Medical Ltd. | 431.44M | 19.62% | 1,300,801 | - |
| 229 | VTVT | vTv Therapeutics Inc. | 426.99M | 6.66% | 34,271 | 17.00K |
| 230 | KROS | Keros Therapeutics, Inc. | 426.23M | 1.44% | 687,560 | 246.72M |
| 231 | XOMA | XOMA Royalty Corporation | 425.48M | 7.11% | 107,814 | 47.11M |
| 232 | LCTX | Lineage Cell Therapeutics, Inc. | 421.65M | - | 839,970 | 10.82M |
| 233 | ENTA | Enanta Pharmaceuticals, Inc. | 414.76M | -1.84% | 197,811 | 65.32M |
| 234 | AURA | Aura Biosciences, Inc. | 410.87M | 1.89% | 200,000 | - |
| 235 | AUTL | Autolus Therapeutics plc | 407.20M | 2.68% | 2,782,198 | 51.13M |
| 236 | PEPG | PepGen Inc. | 402.18M | 2.63% | 553,457 | - |
| 237 | VNDA | Vanda Pharmaceuticals Inc. | 398.90M | 11.39% | 2,265,462 | 212.07M |
| 238 | TENX | Tenax Therapeutics, Inc. | 398.40M | -0.30% | 118,935 | - |
| 239 | IMRX | Immuneering Corporation | 397.75M | -1.28% | 994,020 | - |
| 240 | PRTC | PureTech Health plc | 396.93M | -0.59% | 4,042 | 6.39M |
| 241 | RCKT | Rocket Pharmaceuticals, Inc. | 392.85M | 8.04% | 1,609,536 | - |
| 242 | OCGN | Ocugen, Inc. | 384.15M | 1.65% | 3,176,814 | 5.37M |
| 243 | TRDA | Entrada Therapeutics, Inc. | 379.77M | - | 268,989 | 61.52M |
| 244 | TECX | Tectonic Therapeutic, Inc. | 377.23M | 2.31% | 169,283 | - |
| 245 | MREO | Mereo BioPharma Group plc | 367.59M | 5.96% | 2,582,957 | 500.00K |
| 246 | CTNM | Contineum Therapeutics, Inc. | 365.37M | 0.16% | 107,264 | - |
| 247 | AVXL | Anavex Life Sciences Corp. | 364.54M | -7.48% | 1,609,859 | - |
| 248 | AVTX | Avalo Therapeutics, Inc. | 361.77M | 3.69% | 228,810 | 192.00K |
| 249 | FBRX | Forte Biosciences, Inc. | 361.09M | 0.80% | 73,475 | - |
| 250 | CLLS | Cellectis S.A. | 360.95M | 11.76% | 223,162 | 82.55M |
| 251 | KYTX | Kyverna Therapeutics, Inc. | 358.25M | 3.41% | 289,215 | - |
| 252 | NMRA | Neumora Therapeutics, Inc. | 355.17M | 0.72% | 635,787 | - |
| 253 | ACRS | Aclaris Therapeutics, Inc. | 354.29M | 1.87% | 1,513,898 | 15.74M |
| 254 | GALT | Galectin Therapeutics Inc. | 353.96M | -7.58% | 1,165,012 | - |
| 255 | XFOR | X4 Pharmaceuticals, Inc. | 340.13M | 6.87% | 602,387 | 33.98M |
| 256 | IMMP | Immutep Limited | 337.61M | 11.11% | 1,032,820 | 3.31M |
| 257 | LRMR | Larimar Therapeutics, Inc. | 337.23M | -2.23% | 1,273,638 | - |
| 258 | ALLO | Allogene Therapeutics, Inc. | 332.60M | 4.23% | 2,233,610 | 22.00K |
| 259 | RLMD | Relmada Therapeutics, Inc. | 324.13M | 6.76% | 583,039 | - |
| 260 | NGNE | Neurogene Inc. | 321.57M | 5.17% | 147,008 | 925.00K |
| 261 | GUTS | Fractyl Health, Inc. | 320.68M | 2.18% | 3,371,260 | 3.00K |
| 262 | CADL | Candel Therapeutics, Inc. | 318.41M | 2.47% | 1,098,519 | - |
| 263 | EPRX | Eupraxia Pharmaceuticals Inc. | 317.99M | 5.53% | 24,455 | - |
| 264 | PALI | Palisade Bio, Inc. | 312.91M | 10.53% | 14,153,091 | - |
| 265 | NBY | NovaBay Pharmaceuticals, Inc. | 304.95M | 33.70% | 1,754,705 | 10.30M |
| 266 | AARD | Aardvark Therapeutics, Inc. | 304.39M | 2.12% | 253,458 | - |
| 267 | CYBN | Cybin Inc. | 297.92M | 3.83% | 798,868 | - |
| 268 | ABEO | Abeona Therapeutics Inc. | 296.43M | 4.39% | 2,317,744 | 400.00K |
| 269 | TARA | Protara Therapeutics, Inc. | 296.36M | - | 1,342,177 | - |
| 270 | SLN | Silence Therapeutics plc | 296.16M | 1.13% | 346,110 | 25.83M |
| 271 | ALDX | Aldeyra Therapeutics, Inc. | 288.18M | - | 838,365 | - |
| 272 | OABI | OmniAb, Inc. | 287.91M | 0.50% | 476,938 | 21.09M |
| 273 | CBIO | Crescent Biopharma, Inc. | 283.27M | 3.72% | 199,516 | - |
| 274 | PBYI | Puma Biotechnology, Inc. | 281.69M | 1.27% | 430,416 | 212.00M |
| 275 | SLS | SELLAS Life Sciences Group, Inc. | 279.19M | 3.16% | 4,682,795 | - |
| 276 | ACIU | AC Immune SA | 276.05M | 9.84% | 455,792 | 5.48M |
| 277 | MIST | Milestone Pharmaceuticals Inc. | 271.22M | 1.52% | 3,243,921 | - |
| 278 | CAMP | Camp4 Therapeutics Corporation | 268.16M | 24.35% | 377,200 | 3.80M |
| 279 | PYXS | Pyxis Oncology, Inc. | 267.11M | -0.23% | 283,758 | 2.82M |
| 280 | OBIO | Orchestra BioMed Holdings, Inc. | 263.69M | 11.19% | 537,207 | 2.82M |
| 281 | NAUT | Nautilus Biotechnology, Inc. | 257.66M | - | 357,170 | - |
| 282 | FENC | Fennec Pharmaceuticals Inc. | 254.10M | -2.62% | 97,900 | 38.79M |
| 283 | EDIT | Editas Medicine, Inc. | 253.81M | 6.56% | 2,469,767 | 46.38M |
| 284 | FHTX | Foghorn Therapeutics Inc. | 251.65M | 1.83% | 134,008 | 24.52M |
| 285 | HRTX | Heron Therapeutics, Inc. | 251.21M | 3.01% | 2,460,467 | 155.10M |
| 286 | CCCC | C4 Therapeutics, Inc. | 250.04M | -0.39% | 1,017,569 | 30.11M |
| 287 | AVIR | Atea Pharmaceuticals, Inc. | 246.88M | 0.64% | 317,161 | - |
| 288 | VYGR | Voyager Therapeutics, Inc. | 245.75M | 3.03% | 467,305 | 31.32M |
| 289 | MDWD | MediWound Ltd. | 245.53M | 3.68% | 107,948 | 20.93M |
| 290 | ACHV | Achieve Life Sciences, Inc. | 245.41M | -1.50% | 350,008 | - |
| 291 | ZURA | Zura Bio Limited | 241.89M | -1.06% | 435,924 | - |
| 292 | HUMA | Humacyte, Inc. | 237.83M | - | 3,216,398 | 1.57M |
| 293 | PRQR | ProQR Therapeutics N.V. | 234.92M | -3.88% | 544,509 | 18.86M |
| 294 | TNYA | Tenaya Therapeutics, Inc. | 233.11M | -0.71% | 1,257,180 | - |
| 295 | CABA | Cabaletta Bio, Inc. | 232.96M | -3.20% | 1,839,446 | - |
| 296 | TNXP | Tonix Pharmaceuticals Holding Corp. | 232.59M | 0.77% | 593,865 | 10.30M |
| 297 | IMMX | Immix Biopharma, Inc. | 225.98M | 1.97% | 2,063,059 | - |
| 298 | QNCX | Quince Therapeutics, Inc. | 222.17M | 3.37% | 642,569 | - |
| 299 | ARCT | Arcturus Therapeutics Holdings Inc. | 217.92M | 6.53% | 1,047,551 | 97.60M |
| 300 | TLSA | Tiziana Life Sciences Ltd | 213.88M | 4.05% | 163,034 | - |
| 301 | VOR | Vor Biopharma Inc. | 210.84M | -3.64% | 3,482,842 | - |
| 302 | ARMP | Armata Pharmaceuticals, Inc. | 205.99M | -7.65% | 36,131 | 5.05M |
| 303 | ETHZ | ETHZilla Corporation | 205.74M | -8.19% | 2,033,813 | 4.11M |
| 304 | SGMT | Sagimet Biosciences Inc. | 205.54M | 0.64% | 427,545 | - |
| 305 | SRZN | Surrozen, Inc. | 205.29M | 8.37% | 214,716 | 3.60M |
| 306 | STTK | Shattuck Labs, Inc. | 204.39M | 2.87% | 488,179 | 1.00M |
| 307 | RNAC | Cartesian Therapeutics, Inc. | 204.13M | -0.63% | 262,695 | 1.09M |
| 308 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 190.10M | 1.58% | 337,312 | - |
| 309 | RANI | Rani Therapeutics Holdings, Inc. | 189.57M | 0.65% | 1,634,449 | 1.20M |
| 310 | NVCT | Nuvectis Pharma, Inc. | 189.29M | 5.72% | 141,001 | - |
| 311 | NTHI | NeOnc Technologies Holdings, Inc. | 184.03M | 5.47% | 91,006 | 59.99K |
| 312 | VTGN | Vistagen Therapeutics, Inc. | 178.91M | -0.44% | 499,337 | 721.00K |
| 313 | CRBU | Caribou Biosciences, Inc. | 177.59M | 1.60% | 928,329 | 9.30M |
| 314 | ACTU | Actuate Therapeutics, Inc. | 176.65M | 2.01% | 218,517 | - |
| 315 | SABS | SAB Biotherapeutics, Inc. | 176.62M | -1.33% | 153,049 | 114.70K |
| 316 | IPHA | Innate Pharma S.A. | 176.48M | -2.27% | 9,845 | 14.84M |
| 317 | IKT | Inhibikase Therapeutics, Inc. | 173.33M | 1.37% | 224,063 | 1.00 |
| 318 | IRD | Opus Genetics, Inc. | 172.41M | 4.60% | 855,359 | 14.63M |
| 319 | GNLX | Genelux Corporation | 169.66M | -0.88% | 97,875 | 8.00K |
| 320 | ANIX | Anixa Biosciences, Inc. | 168.86M | 1.38% | 445,399 | - |
| 321 | CRDF | Cardiff Oncology, Inc. | 165.03M | 1.66% | 869,479 | 501.00K |
| 322 | CDXS | Codexis, Inc. | 164.39M | -2.41% | 1,478,295 | 52.93M |
| 323 | SGMO | Sangamo Therapeutics, Inc. | 162.39M | -4.11% | 3,359,836 | 32.88M |
| 324 | CHRS | Coherus Oncology, Inc. | 160.76M | 3.10% | 1,037,485 | 277.73M |
| 325 | SAVA | Cassava Sciences, Inc. | 157.48M | 0.62% | 568,261 | - |
| 326 | MOLN | Molecular Partners AG | 155.79M | -0.60% | 1,568 | 856.30K |
| 327 | MCRB | Seres Therapeutics, Inc. | 153.61M | 1.19% | 104,651 | 351.00K |
| 328 | CGEN | Compugen Ltd. | 152.46M | -1.21% | 322,445 | 6.90M |
| 329 | BDTX | Black Diamond Therapeutics, Inc. | 152.12M | -1.48% | 1,233,227 | 70.00M |
| 330 | GANX | Gain Therapeutics, Inc. | 151.49M | 3.21% | 829,334 | - |
| 331 | CGTX | Cognition Therapeutics, Inc. | 149.18M | 0.60% | 801,792 | - |
| 332 | INO | Inovio Pharmaceuticals, Inc. | 149.09M | -0.46% | 1,227,310 | 182.34K |
| 333 | PLX | Protalix BioTherapeutics, Inc. | 144.76M | 2.86% | 525,279 | 61.84M |
| 334 | ALEC | Alector, Inc. | 141.90M | 1.56% | 977,323 | 69.05M |
| 335 | CLYM | Climb Bio, Inc. | 141.82M | 9.47% | 849,002 | - |
| 336 | UNCY | Unicycive Therapeutics, Inc. | 141.63M | 1.07% | 312,869 | - |
| 337 | KLRS | Kalaris Therapeutics, Inc. | 141.58M | 6.32% | 128,987 | - |
| 338 | ELTX | Elicio Therapeutics, Inc. | 141.29M | -0.06% | 109,522 | - |
| 339 | MRSN | Mersana Therapeutics, Inc. | 140.51M | -0.11% | 60,634 | 33.18M |
| 340 | GLSI | Greenwich LifeSciences, Inc. | 140.07M | 2.22% | 95,692 | - |
| 341 | AGEN | Agenus Inc. | 139.09M | 4.34% | 494,094 | 106.83M |
| 342 | PRLD | Prelude Therapeutics Incorporated | 135.96M | -2.94% | 235,251 | 10.50M |
| 343 | EXOZ | eXoZymes, Inc. | 134.28M | 14.28% | 12,459 | -700.00 |
| 344 | NKTX | Nkarta, Inc. | 133.54M | -1.05% | 542,597 | - |
| 345 | VRCA | Verrica Pharmaceuticals Inc. | 131.76M | -0.36% | 135,486 | 30.83M |
| 346 | CNTB | Connect Biopharma Holdings Limited | 131.37M | -1.26% | 83,515 | 762.00K |
| 347 | SPRO | Spero Therapeutics, Inc. | 131.27M | - | 335,473 | 40.55M |
| 348 | ACOG | Alpha Cognition Inc. | 130.45M | 0.17% | 11,772 | 7.43M |
| 349 | ELDN | Eledon Pharmaceuticals, Inc. | 127.75M | 8.97% | 2,020,376 | - |
| 350 | COYA | Coya Therapeutics, Inc. | 127.43M | -0.81% | 208,146 | 3.99M |
| 351 | FATE | Fate Therapeutics, Inc. | 125.73M | 3.81% | 1,437,008 | 7.14M |
| 352 | WHWK | Whitehawk Therapeutics, Inc. | 122.06M | 0.78% | 97,731 | 14.38M |
| 353 | ATRA | Atara Biotherapeutics, Inc. | 121.35M | 7.27% | 132,716 | 151.93M |
| 354 | DTIL | Precision BioSciences, Inc. | 120.60M | 3.09% | 159,976 | 698.00K |
| 355 | SLGL | Sol-Gel Technologies Ltd. | 117.84M | 5.41% | 10,471 | 18.97M |
| 356 | ORMP | Oramed Pharmaceuticals Inc. | 115.43M | 8.21% | 241,365 | 2.00M |
| 357 | OVID | Ovid Therapeutics Inc. | 115.36M | 3.18% | 1,410,925 | 6.61M |
| 358 | ABOS | Acumen Pharmaceuticals, Inc. | 115.09M | -2.56% | 90,566 | - |
| 359 | CNTX | Context Therapeutics Inc. | 114.05M | 2.88% | 857,384 | - |
| 360 | ANVS | Annovis Bio, Inc. | 111.31M | -5.83% | 778,653 | - |
| 361 | KPTI | Karyopharm Therapeutics Inc. | 109.81M | 0.78% | 160,882 | 142.53M |
| 362 | ATOS | Atossa Therapeutics, Inc. | 109.80M | 5.11% | 1,025,418 | - |
| 363 | BMEA | Biomea Fusion, Inc. | 108.88M | 14.93% | 3,216,046 | - |
| 364 | VANI | Vivani Medical, Inc. | 107.97M | -2.63% | 216,954 | - |
| 365 | ONCY | Oncolytics Biotech Inc. | 105.04M | 1.31% | 392,308 | - |
| 366 | ZNTL | Zentalis Pharmaceuticals, Inc. | 102.60M | 2.90% | 354,667 | 26.87M |
| 367 | SEER | Seer, Inc. | 102.09M | -0.54% | 220,011 | 16.38M |
| 368 | ENTX | Entera Bio Ltd. | 97.22M | 2.42% | 37,219 | 124.00K |
| 369 | THAR | Tharimmune, Inc. | 94.27M | 3.46% | 226,017 | - |
| 370 | OTLK | Outlook Therapeutics, Inc. | 92.84M | 0.48% | 1,900,405 | 1.51M |
| 371 | RPTX | Repare Therapeutics Inc. | 92.42M | -0.46% | 806,611 | 11.87M |
| 372 | PSTV | Plus Therapeutics, Inc. | 92.38M | 0.33% | 2,795,464 | 5.26M |
| 373 | SPRB | Spruce Biosciences, Inc. | 91.70M | -9.96% | 48,643 | 697.00K |
| 374 | FBIO | Fortress Biotech, Inc. | 91.25M | 3.52% | 236,981 | 62.30M |
| 375 | CBUS | Cibus, Inc. | 90.11M | -1.78% | 134,749 | 3.79M |
| 376 | TTRX | Turn Therapeutics Inc. | 89.81M | -9.23% | 81,099 | - |
| 377 | ACET | Adicet Bio, Inc. | 88.73M | 2.33% | 3,139,575 | - |
| 378 | MGNX | MacroGenics, Inc. | 88.56M | 0.72% | 1,612,921 | 127.63M |
| 379 | ANEB | Anebulo Pharmaceuticals, Inc. | 88.33M | -3.15% | 30,506 | - |
| 380 | TVGN | Tevogen Bio Holdings Inc. | 86.99M | -2.93% | 1,226,929 | - |
| 381 | HYFT | MindWalk Holdings Corp. | 86.77M | -3.09% | 281,651 | 18.21M |
| 382 | VXRT | Vaxart, Inc. | 86.54M | -1.11% | - | 148.20M |
| 383 | ADAG | Adagene Inc. | 85.31M | -5.43% | 144,555 | 103.20K |
| 384 | CSBR | Champions Oncology, Inc. | 84.94M | -1.75% | 7,130 | 56.88M |
| 385 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 83.99M | 5.45% | 7,820,352 | - |
| 386 | ALXO | ALX Oncology Holdings Inc. | 83.50M | 4.76% | 214,458 | - |
| 387 | BYSI | BeyondSpring Inc. | 83.07M | 4.12% | 22,433 | 1.88M |
| 388 | ACRV | Acrivon Therapeutics, Inc. | 82.67M | 5.22% | 376,904 | - |
| 389 | IMUX | Immunic, Inc. | 82.15M | 1.88% | 819,352 | - |
| 390 | COEP | Coeptis Therapeutics Holdings, Inc. | 80.37M | -3.59% | 157,667 | 501.00K |
| 391 | CRVO | CervoMed Inc. | 80.22M | 0.46% | 45,474 | 6.16M |
| 392 | ATYR | aTyr Pharma, Inc. | 79.96M | 0.95% | 2,674,516 | 190.00K |
| 393 | ESLA | Estrella Immunopharma, Inc. | 78.93M | -1.42% | 123,000 | - |
| 394 | XBIT | XBiotech Inc. | 78.66M | 7.50% | 113,048 | - |
| 395 | PLRX | Pliant Therapeutics, Inc. | 78.66M | 1.59% | 1,040,259 | - |
| 396 | PTHS | Pelthos Therapeutics Inc. | 77.26M | -1.15% | 5,752 | 7.41M |
| 397 | TIL | Instil Bio, Inc. | 77.25M | 3.17% | 44,461 | - |
| 398 | STRO | Sutro Biopharma, Inc. | 76.62M | 6.01% | 127,609 | 105.65M |
| 399 | OKYO | OKYO Pharma Limited | 75.97M | 2.54% | 54,587 | - |
| 400 | ARTV | Artiva Biotherapeutics, Inc. | 75.35M | -1.60% | 136,393 | 251.00K |
| 401 | MNOV | MediciNova, Inc. | 74.06M | -1.95% | 111,193 | 257.92K |
| 402 | KRRO | Korro Bio, Inc. | 73.74M | 8.00% | 333,013 | 7.37M |
| 403 | IFRX | InflaRx N.V. | 71.13M | -0.94% | 554,924 | 73.73K |
| 404 | OSTX | OS Therapies Incorporated | 70.08M | 1.53% | 744,482 | - |
| 405 | ALGS | Aligos Therapeutics, Inc. | 69.72M | 2.26% | 88,182 | 2.65M |
| 406 | IMA | ImageneBio, Inc. | 68.49M | -2.72% | 35,406 | 800.00K |
| 407 | MGX | Metagenomi, Inc. | 68.34M | 1.68% | 309,421 | 30.91M |
| 408 | LITS | Lite Strategy, Inc. | 67.69M | 0.55% | 281,462 | - |
| 409 | PMVP | PMV Pharmaceuticals, Inc. | 67.05M | 1.61% | 223,038 | - |
| 410 | PYPD | PolyPid Ltd. | 66.71M | 0.75% | 92,644 | - |
| 411 | CALC | CalciMedica, Inc. | 65.71M | -1.51% | 113,804 | - |
| 412 | EQ | Equillium, Inc. | 65.16M | 18.89% | 1,382,460 | 4.39M |
| 413 | ATHE | Alterity Therapeutics Limited | 64.99M | -0.30% | 9,891 | 3.57M |
| 414 | IBIO | iBio, Inc. | 63.19M | 26.58% | 67,027,536 | 500.00K |
| 415 | NRXP | NRx Pharmaceuticals, Inc. | 62.10M | -5.96% | 754,799 | 242.00K |
| 416 | INKT | MiNK Therapeutics, Inc. | 59.80M | -1.92% | 26,367 | - |
| 417 | INMB | INmune Bio, Inc. | 59.29M | 2.76% | 781,794 | 50.00K |
| 418 | NTRB | Nutriband Inc. | 58.76M | -0.81% | 13,657 | 2.58M |
| 419 | TCRX | TScan Therapeutics, Inc. | 58.45M | 1.48% | 432,764 | 8.42M |
| 420 | IOBT | IO Biotech, Inc. | 58.28M | -4.32% | 323,489 | - |
| 421 | PDSB | PDS Biotechnology Corporation | 55.82M | -3.77% | 1,083,193 | - |
| 422 | ICCC | ImmuCell Corporation | 53.10M | 5.39% | 66,381 | 27.77M |
| 423 | EVAX | Evaxion A/S | 52.89M | -3.92% | 98,769 | 7.65M |
| 424 | HURA | TuHURA Biosciences, Inc. | 52.80M | -11.97% | 1,702,812 | - |
| 425 | ABVC | ABVC BioPharma, Inc. | 52.56M | - | 80,626 | 797.92K |
| 426 | CVM | CEL-SCI Corporation | 52.34M | -1.95% | 59,722 | - |
| 427 | JSPR | Jasper Therapeutics, Inc. | 52.33M | 5.65% | 827,789 | - |
| 428 | IBO | Impact BioMedical Inc. | 52.31M | -6.58% | 97,658 | 25.00K |
| 429 | HOWL | Werewolf Therapeutics, Inc. | 51.94M | 5.94% | 633,224 | 1.14M |
| 430 | IPSC | Century Therapeutics, Inc. | 51.65M | -0.02% | 697,855 | 113.34M |
| 431 | MAIA | MAIA Biotechnology, Inc. | 51.10M | 2.22% | 2,022,792 | - |
| 432 | CELU | Celularity Inc. | 50.71M | -1.10% | 68,759 | 40.58M |
| 433 | TELO | Telomir Pharmaceuticals, Inc. | 48.48M | -1.40% | 202,106 | - |
| 434 | GRCE | Grace Therapeutics, Inc. | 47.90M | -2.31% | 42,846 | - |
| 435 | BTAI | BioXcel Therapeutics, Inc. | 47.89M | 2.82% | 600,301 | 752.00K |
| 436 | OKUR | OnKure Therapeutics, Inc. | 47.01M | 4.20% | 74,555 | - |
| 437 | KZR | Kezar Life Sciences, Inc. | 46.50M | 1.60% | 44,181 | - |
| 438 | BCAB | BioAtla, Inc. | 45.49M | -3.92% | 1,072,004 | 11.00M |
| 439 | ATNM | Actinium Pharmaceuticals, Inc. | 44.30M | -0.70% | 155,612 | 90.00K |
| 440 | ANL | Adlai Nortye Ltd. | 44.28M | 9.09% | 111,898 | 1.94M |
| 441 | LTRN | Lantern Pharma Inc. | 42.72M | -1.55% | 47,908 | - |
| 442 | TVRD | Tvardi Therapeutics, Inc. | 42.50M | 5.59% | 146,578 | - |
| 443 | VERU | Veru Inc. | 41.25M | -2.28% | 45,634 | 16.89M |
| 444 | QTTB | Q32 Bio Inc. | 41.10M | 3.09% | 298,696 | - |
| 445 | GNTA | Genenta Science S.p.A. | 41.01M | -1.69% | 63,561 | - |
| 446 | QNTM | Quantum BioPharma Ltd. | 40.68M | -0.19% | 74,495 | - |
| 447 | NXTC | NextCure, Inc. | 39.61M | 4.94% | 50,995 | - |
| 448 | SNTI | Senti Biosciences, Inc. | 39.17M | -3.25% | 7,443,010 | - |
| 449 | RNTX | Rein Therapeutics Inc. | 39.17M | 2.76% | 181,976 | - |
| 450 | GLTO | Galecto, Inc. | 39.09M | 5.97% | 270,001 | - |
| 451 | JUNS | Jupiter Neurosciences, Inc. | 38.90M | - | 40,668 | - |
| 452 | APLM | Apollomics, Inc. | 38.27M | -0.94% | 30,312 | 198.00K |
| 453 | XLO | Xilio Therapeutics, Inc. | 37.70M | -1.93% | 506,007 | 31.80M |
| 454 | CUE | Cue Biopharma, Inc. | 37.58M | -3.50% | 247,210 | 7.10M |
| 455 | GBIO | Generation Bio Co. | 37.13M | 2.42% | 24,759 | 15.27M |
| 456 | SKYE | Skye Bioscience, Inc. | 36.55M | -5.79% | 251,784 | - |
| 457 | DYAI | Dyadic International, Inc. | 35.83M | -1.00% | 112,827 | 3.34M |
| 458 | RNXT | RenovoRx, Inc. | 35.80M | 1.76% | 197,352 | 928.00K |
| 459 | FGEN | FibroGen, Inc. | 35.68M | 3.64% | 15,670 | 8.30M |
| 460 | SER | Serina Therapeutics, Inc. | 34.23M | -3.02% | 2,862 | 116.00K |
| 461 | XCUR | Exicure, Inc. | 33.91M | -27.02% | 1,129,773 | 500.00K |
| 462 | RADX | Radiopharm Theranostics Limited | 33.39M | 1.18% | 66,381 | 8.20M |
| 463 | PASG | Passage Bio, Inc. | 33.07M | 0.05% | 58,495 | - |
| 464 | INTS | Intensity Therapeutics, Inc. | 33.04M | 4.30% | 4,419,388 | - |
| 465 | PLUR | Pluri Inc. | 32.76M | 2.91% | 192,738 | 1.33M |
| 466 | RLYB | Rallybio Corporation | 32.53M | 6.54% | 415,099 | 674.00K |
| 467 | ANTX | AN2 Therapeutics, Inc. | 32.33M | 2.61% | 63,954 | - |
| 468 | KLTO | Klotho Neurosciences, Inc. | 31.81M | -2.56% | 377,953 | - |
| 469 | IGC | IGC Pharma, Inc. | 31.76M | 14.77% | 1,624,120 | 1.11M |
| 470 | APLT | Applied Therapeutics, Inc. | 31.75M | -12.18% | 10,675,895 | 1.00M |
| 471 | NRXS | NeurAxis, Inc. | 29.40M | 2.22% | 25,601 | 3.36M |
| 472 | BRNS | Barinthus Biotherapeutics plc | 28.74M | 3.85% | 130,580 | 14.97M |
| 473 | DARE | Daré Bioscience, Inc. | 28.44M | 6.99% | 605,342 | -57.13K |
| 474 | LNAI | Lunai Bioworks Inc. | 27.88M | -5.56% | 302,777 | - |
| 475 | HYPD | Hyperion DeFi, Inc. | 27.43M | 1.86% | 180,479 | 345.32K |
| 476 | NERV | Minerva Neurosciences, Inc. | 27.34M | 0.26% | 45,171 | - |
| 477 | CING | Cingulate Inc. | 26.69M | 1.02% | 89,109 | - |
| 478 | KTTA | Pasithea Therapeutics Corp. | 25.98M | -0.85% | 367,583 | - |
| 479 | BOLD | Boundless Bio, Inc. | 25.97M | -1.69% | 110,546 | - |
| 480 | LEXX | Lexaria Bioscience Corp. | 25.78M | 2.65% | 301,590 | 705.92K |
| 481 | ITRM | Iterum Therapeutics plc | 24.28M | 1.55% | 166,116 | 390.00K |
| 482 | MRKR | Marker Therapeutics, Inc. | 24.18M | -2.68% | 249,012 | 4.69M |
| 483 | LIMN | Liminatus Pharma, Inc. | 24.16M | 1.94% | 74,996 | - |
| 484 | LIXT | Lixte Biotechnology Holdings, Inc. | 24.07M | 0.24% | 85,616 | - |
| 485 | NNVC | NanoViricides, Inc. | 23.76M | -3.65% | 271,428 | - |
| 486 | KZIA | Kazia Therapeutics Limited | 23.48M | -17.79% | 254,704 | 1.20M |
| 487 | ENLV | Enlivex Therapeutics Ltd. | 23.32M | -5.88% | 666,185 | - |
| 488 | CLGN | CollPlant Biotechnologies Ltd. | 23.13M | 2.26% | 11,347 | 2.48M |
| 489 | CVKD | Cadrenal Therapeutics, Inc. | 23.06M | 11.43% | 68,520 | - |
| 490 | NEUP | Neuphoria Therapeutics Inc. | 22.64M | -8.48% | 109,555 | 15.65M |
| 491 | PTN | Palatin Technologies, Inc. | 22.39M | -6.84% | 47,601 | 8.85M |
| 492 | PLRZ | Polyrizon Ltd. | 21.97M | 3.82% | 401,625 | - |
| 493 | NRSN | NeuroSense Therapeutics Ltd. | 21.91M | -7.89% | 1,209,812 | - |
| 494 | CTXR | Citius Pharmaceuticals, Inc. | 21.61M | -2.50% | 327,895 | - |
| 495 | BCTX | BriaCell Therapeutics Corp. | 21.31M | -7.90% | 97,271 | - |
| 496 | MTVA | MetaVia Inc. | 21.02M | 10.53% | 356,852 | - |
| 497 | FBLG | FibroBiologics, Inc. | 20.33M | 12.82% | 2,062,614 | - |
| 498 | APVO | Aptevo Therapeutics Inc. | 20.22M | -3.23% | 8,261,131 | - |
| 499 | TRAW | Traws Pharma, Inc. | 19.74M | 1.65% | 86,281 | 2.85M |
| 500 | PMN | ProMIS Neurosciences, Inc. | 19.59M | 11.93% | 54,432 | - |
| 501 | NCEL | NewcelX Ltd. | 19.42M | -6.37% | 338,194 | - |
| 502 | HOTH | Hoth Therapeutics, Inc. | 18.77M | 1.68% | 165,200 | - |
| 503 | ALLR | Allarity Therapeutics, Inc. | 18.50M | 2.63% | 281,127 | - |
| 504 | LPCN | Lipocine Inc. | 18.32M | 0.92% | 10,011 | 4.32M |
| 505 | LSTA | Lisata Therapeutics, Inc. | 18.17M | 3.00% | 34,631 | 1.07M |
| 506 | GDTC | CytoMed Therapeutics Limited | 17.97M | 0.47% | 32,054 | 573.19K |
| 507 | NCNA | NuCana plc | 17.77M | -0.23% | 101,750 | - |
| 508 | KAPA | Kairos Pharma, Ltd. | 17.49M | -2.23% | 83,899 | - |
| 509 | CASI | CASI Pharmaceuticals, Inc. | 17.33M | -1.56% | 25,318 | 26.85M |
| 510 | CLRB | Cellectar Biosciences, Inc. | 17.05M | 2.55% | 62,076 | - |
| 511 | CRIS | Curis, Inc. | 16.81M | -2.26% | 97,159 | 11.65M |
| 512 | OSRH | OSR Holdings, Inc. | 16.66M | -4.95% | 863,340 | -90.52K |
| 513 | SNGX | Soligenix, Inc. | 16.14M | 0.63% | 369,033 | 2.34K |
| 514 | CANF | Can-Fite BioPharma Ltd. | 15.82M | -2.21% | 490,045 | 560.00K |
| 515 | ABP | Abpro Holdings, Inc. | 15.75M | -2.36% | 20,313 | 183.00K |
| 516 | PCSA | Processa Pharmaceuticals, Inc. | 15.68M | -9.18% | 987,745 | - |
| 517 | ATHA | Athira Pharma, Inc. | 15.62M | -1.25% | 9,912 | - |
| 518 | BCDA | BioCardia, Inc. | 15.60M | 1.38% | 65,141 | 3.00K |
| 519 | TPST | Tempest Therapeutics, Inc. | 15.52M | -1.56% | 75,802 | - |
| 520 | CMMB | Chemomab Therapeutics Ltd. | 15.20M | -5.00% | 184,413 | - |
| 521 | COCP | Cocrystal Pharma, Inc. | 14.75M | 0.94% | 42,638 | - |
| 522 | PULM | Pulmatrix, Inc. | 14.43M | -9.61% | 11,826 | 3.00K |
| 523 | DWTX | Dogwood Therapeutics, Inc. | 13.71M | -0.50% | 86,389 | - |
| 524 | BLRX | BioLineRx Ltd. | 13.71M | 1.85% | 50,799 | 12.74M |
| 525 | AKTX | Akari Therapeutics, Plc | 13.58M | 8.29% | 815,887 | - |
| 526 | VYNE | VYNE Therapeutics Inc. | 13.45M | 7.22% | 2,013,506 | 524.00K |
| 527 | LGVN | Longeveron Inc. | 13.38M | -3.51% | 179,629 | 1.44M |
| 528 | SYBX | Synlogic, Inc. | 13.10M | 7.69% | 56,224 | 8.00K |
| 529 | IMNN | Imunon, Inc. | 12.83M | 5.29% | 118,767 | - |
| 530 | PHIO | Phio Pharmaceuticals Corp. | 12.59M | 1.74% | 222,895 | - |
| 531 | EDSA | Edesa Biotech, Inc. | 12.39M | -1.68% | 24,296 | - |
| 532 | ICU | SeaStar Medical Holding Corporation | 12.26M | -4.60% | 892,484 | 881.00K |
| 533 | BIVI | BioVie Inc. | 11.91M | 1.94% | 79,189 | - |
| 534 | GOVX | GeoVax Labs, Inc. | 11.76M | -0.55% | 374,381 | 3.35M |
| 535 | BOLT | Bolt Biotherapeutics, Inc. | 11.13M | -1.19% | 33,185 | 5.20M |
| 536 | APM | Aptorum Group Limited | 10.99M | 2.27% | 38,338 | - |
| 537 | CLDI | Calidi Biotherapeutics, Inc. | 10.98M | -1.32% | 60,403 | - |
| 538 | PPCB | Propanc Biopharma, Inc. | 10.84M | 0.10% | 53,981 | - |
| 539 | SNSE | Sensei Biotherapeutics, Inc. | 10.81M | 7.53% | 42,420 | - |
| 540 | ERNA | Ernexa Therapeutics Inc. | 10.05M | -5.88% | 44,751 | 1,000.00 |
| 541 | QNRX | Quoin Pharmaceuticals, Ltd. | 10.00M | -3.95% | 28,058 | - |
| 542 | MBRX | Moleculin Biotech, Inc. | 9.84M | -27.15% | 601,364 | - |
| 543 | BRTX | BioRestorative Therapies, Inc. | 9.76M | 2.80% | 44,428 | 383.40K |
| 544 | TCRT | Alaunos Therapeutics, Inc. | 9.62M | 8.02% | 52,593 | 6.00K |
| 545 | SLXN | Silexion Therapeutics Corp | 9.44M | -1.31% | 49,071 | - |
| 546 | EVGN | Evogene Ltd. | 9.40M | 0.92% | 21,446 | 8.02M |
| 547 | ASBP | Aspire Biopharma Holdings, Inc. | 9.17M | -5.75% | 9,021,887 | 1.94K |
| 548 | MBIO | Mustang Bio, Inc. | 9.12M | -0.79% | 69,588 | - |
| 549 | AEON | AEON Biopharma, Inc. | 9.06M | 5.72% | 216,225 | - |
| 550 | ACXP | Acurx Pharmaceuticals, Inc. | 8.95M | 1.18% | 62,524 | - |
| 551 | GRDX | GridAI Technologies Corp. | 8.74M | 8.20% | 73,646 | - |
| 552 | ALZN | Alzamend Neuro, Inc. | 8.29M | 0.46% | 78,182 | - |
| 553 | KALA | KALA BIO, Inc. | 8.26M | -2.06% | 2,516,197 | - |
| 554 | INAB | IN8bio, Inc. | 8.20M | 2.91% | 39,157 | - |
| 555 | XTLB | XTL Biopharmaceuticals Ltd. | 8.17M | -5.28% | 35,160 | 451.00K |
| 556 | CELZ | Creative Medical Technology Holdings, Inc. | 8.10M | - | 71,469 | 6.00K |
| 557 | RNAZ | TransCode Therapeutics, Inc. | 7.91M | 2.62% | 15,240 | - |
| 558 | ADXN | Addex Therapeutics Ltd | 7.84M | -0.07% | 3,162 | 198.82K |
| 559 | KPRX | Kiora Pharmaceuticals, Inc. | 7.78M | 2.91% | 21,582 | 20.00K |
| 560 | GNPX | Genprex, Inc. | 7.56M | 2.78% | 109,636 | - |
| 561 | TOVX | Theriva Biologics, Inc. | 7.47M | -0.67% | 1,014,187 | - |
| 562 | PPBT | Purple Biotech Ltd | 7.46M | 1.28% | 282,845 | - |
| 563 | ADIL | Adial Pharmaceuticals, Inc. | 7.41M | 0.36% | 182,189 | - |
| 564 | BGMS | Bio Green Med Solution, Inc. | 7.30M | -8.59% | 54,530 | 81.00K |
| 565 | IMRN | Immuron Limited | 7.20M | -25.83% | 478,770 | 4.78M |
| 566 | GTBP | GT Biopharma, Inc. | 7.15M | 5.08% | 1,270,308 | - |
| 567 | LYRA | Lyra Therapeutics, Inc. | 7.15M | 1.77% | 23,432 | 600.00K |
| 568 | PMCB | PharmaCyte Biotech, Inc. | 7.07M | -6.31% | 1,763,538 | - |
| 569 | CDIO | Cardio Diagnostics Holdings, Inc. | 6.88M | -2.08% | 18,883 | 15.78K |
| 570 | CMND | Clearmind Medicine Inc. | 6.86M | -6.08% | 12,451,399 | - |
| 571 | CYCN | Cyclerion Therapeutics, Inc. | 6.55M | 3.61% | 33,290 | 2.86M |
| 572 | REVB | Revelation Biosciences, Inc. | 6.46M | 2.83% | 163,375 | - |
| 573 | ENVB | Enveric Biosciences, Inc. | 6.17M | 74.49% | 35,034,700 | - |
| 574 | VIVS | VivoSim Labs, Inc. | 6.13M | -0.42% | 15,528 | 140.00K |
| 575 | SILO | Silo Pharma, Inc. | 5.86M | -0.43% | 201,400 | 72.10K |
| 576 | GLMD | Galmed Pharmaceuticals Ltd. | 5.81M | -8.62% | 250,026 | - |
| 577 | APRE | Aprea Therapeutics, Inc. | 5.76M | -1.67% | 108,838 | 488.24K |
| 578 | ENSC | Ensysce Biosciences, Inc. | 5.74M | 11.27% | 655,757 | 4.49M |
| 579 | XBIO | Xenetic Biosciences, Inc. | 5.50M | -2.56% | 82,495 | 2.86M |
| 580 | JAGX | Jaguar Health, Inc. | 5.45M | 13.68% | 2,230,048 | 11.79M |
| 581 | HCWB | HCW Biologics Inc. | 5.40M | 4.17% | 44,516 | 422.03K |
| 582 | SLRX | Salarius Pharmaceuticals, Inc. | 5.09M | 4.48% | 334,357 | - |
| 583 | MTNB | Matinas BioPharma Holdings, Inc. | 5.06M | -6.12% | 36,907 | - |
| 584 | CNSP | CNS Pharmaceuticals, Inc. | 4.67M | 7.73% | 52,264 | - |
| 585 | INDP | Indaptus Therapeutics, Inc. | 4.64M | 1.92% | 26,680 | - |
| 586 | ONCO | Onconetix, Inc. | 4.37M | 1.01% | 83,303 | 1.22M |
| 587 | XRTX | XORTX Therapeutics Inc. | 4.21M | -3.83% | 41,584 | - |
| 588 | PHGE | BiomX Inc. | 4.20M | 12.70% | 122,559 | - |
| 589 | BDRX | Biodexa Pharmaceuticals Plc | 4.16M | 65.11% | 16,774,622 | 104.90K |
| 590 | AZTR | Azitra, Inc. | 4.11M | 1.59% | 188,347 | 7.50K |
| 591 | OGEN | Oragenics, Inc. | 4.03M | -1.74% | 56,449 | - |
| 592 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 3.98M | -2.29% | 70,447 | 1.36M |
| 593 | GRI | GRI Bio, Inc. | 3.96M | -12.95% | 7,809,389 | - |
| 594 | SCNI | Scinai Immunotherapeutics Ltd. | 3.92M | -0.81% | 26,677 | 1.15M |
| 595 | ARTL | Artelo Biosciences, Inc. | 3.84M | 2.15% | 105,534 | - |
| 596 | PTIX | Protagenic Therapeutics, Inc. | 3.25M | 3.70% | 100,135 | - |
| 597 | CDT | CDT Equity Inc. | 3.24M | 12.43% | 997,347 | - |
| 598 | ELAB | PMGC Holdings Inc. | 3.21M | -1.59% | 125,907 | 285.95K |
| 599 | VRAX | Virax Biolabs Group Limited | 3.20M | 4.22% | 531,192 | 2.99K |
| 600 | SPRC | SciSparc Ltd. | 3.18M | -12.50% | 259,509 | 1.31M |
| 601 | DRMA | Dermata Therapeutics, Inc. | 2.98M | - | 157,916 | - |
| 602 | PBM | Psyence Biomedical Ltd. | 2.86M | -3.77% | 874,661 | - |
| 603 | MLEC | Moolec Science SA | 1.87M | 3.81% | 112,950 | 7.83M |
| 604 | ADTX | Aditxt, Inc. | 1.43M | -19.56% | 1,098,834 | 5.95K |